Closing date 20-Oct-2020 5:00 pm
Total pool $3M
This is focussed around information and technology.
Survivorship research must be focused on children, adolescents and young adults, or adults with malignant brain cancer, their families or carers.
Areas of focus may include:
- research into new educational and communication methods and approaches, including special approaches and considerations for underserved and at-risk populations
- research on new methods and strategies to disseminate cancer information/innovation to healthcare providers (e.g., web-based information, telemedicine, smartphone apps etc.) and the effectiveness of these approaches
- research on new communication processes and/or methods and information technologies with the health care system and the effectiveness of these approaches.
2) Heart Foundation Strategic Grants (MRFF Co-funded)
These grants aim to generate innovative and collaborative research projects in the areas where identified gaps in cardiovascular health exist, with a focus on four specific areas. Applications may relate to any research discipline (i.e. biomedical, clinical, public health, health services) or be multidisciplinary. All four grants will run in two stages, with stage one success required to progress to stage two. For stage one, applicants must submit a ‘Letter of Intent’ style application, via the Heart Foundation Portal. Successful applicants in stage one will be invited to submit additional application details.
The four (stage one) deadlines are:
- 14 Aug 2020: Cardio-oncology
- 14 Aug 2020: Predictive Modelling
- 11 Sep 2020: Secondary Prevention
- 11 Sep 2020: Women and Heart Disease
The total funding available is $8 million (2 grants per stream at up to $1M per grant)
CIA can only lead one application to each topic, but can be named (as non-lead) on a different submission (even in the same topic).
Applicants will be experienced senior researchers, have a significant track record, national and/or international collaborative team, and an ability to attract further funding for the program.
Submission is via online portal, and requires MRO endorsement in the portal prior to the deadline. Therefore ensure that you contact mhs@monash.edu and start a Pure application record so they are aware of your application(s).
Research Development Support
The Research Development Team is available to provide advice to applicants on how to address the assessment criteria effectively and for strategic review of complete drafts. We encourage researchers to seek this support earlier rather than later, as capacity is limited and time should be allowed for a compliance check, as below.
KEY DATES
Cardio-Oncology and Predictive Modelling Grants
- 31 July 2020: - MRO compliance deadline (eligibility & compliance review, via Pure)
- 12 August 2020: - MRO endorsement deadline (finalised in Heart Foundation portal)
- 14 August 2020: - Heart Foundation stage one deadline (5pm AEST)
Women and Heart Disease and Secondary Prevention Grants
- 3 August 2020: Heart Foundation portal opens
- 28 August 2020: - MRO compliance deadline (eligibility & compliance review, via Pure)
- 9 September 2020: - MRO endorsement deadline (finalised in Heart Foundation portal)
- 11 September 2020: - Heart Foundation stage one deadline (5pm AEST)
FORECAST MRFF GRANTS
1) MRFF – 2020 COVID-19 Vaccine Candidate Research Grant Opportunity
This is a series of 3 Expression of Interest rounds.
Only applicants successful under the Expression of Interest stage will be invited to submit full applications. Round 1 EoIs are submitted.
Closing dates for EoI's in Round 2 and Round 3
- Round 2: 5pm ACT local time 11 November 2020
- Round 3: 5pm ACT local time 10 March 2021
Total pool $13.65M (across all rounds)
Maximum individual Grant size $3M
As always, please let Karen McConalogue know if you intend to apply so she can see how she can assist you.
No comments:
Post a Comment